Integrated Palliative Care for Patients Referred for Chimeric Antigen Receptor (CAR) T-Cell Therapy: A Service Evaluation

被引:3
|
作者
Williams, Rebekah [1 ,2 ,3 ]
Droney, Joanne [1 ,2 ]
Nicholson, Emma [1 ,2 ]
Gonzalez, Carlos [1 ,2 ]
Ellard, Rose [1 ,2 ]
Bradley, Nathalie [1 ,2 ]
Maycock, Celvin [1 ,2 ]
Halley, Angela [1 ,2 ]
机构
[1] Royal Marsden Hosp, Symptom Control & Palliat Care Dept, Sutton, England
[2] Royal Marsden Hosp, Haematol Dept, Sutton, England
[3] Royal Marsden Hosp, Fulham Rd, London SW3 6JJ, England
关键词
D O I
10.1016/j.jpainsymman.2023.11.002
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
引用
下载
收藏
页码:e157 / e159
页数:3
相关论文
共 50 条
  • [21] Development of chimeric antigen receptor (CAR) T-cell immunotherapy
    Borchmann, P.
    ONCOLOGY RESEARCH AND TREATMENT, 2016, 39 : 27 - 27
  • [22] NURSING IMPLICATIONS FOR MULTIPLE MYELOMA PATIENTS UNDERGOING CHIMERIC ANTIGEN RECEPTOR (CAR) T-CELL THERAPY
    Florendo, Erika
    Catamero, Donna
    Mancia, Ines Stefania
    ONCOLOGY NURSING FORUM, 2019, 46 (02)
  • [23] Nursing implications for multiple myeloma patients undergoing chimeric antigen receptor (CAR) T-cell therapy
    Florendo, Erika
    Catamero, Donna
    Mancia, Ines Stefania
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2019, 19 (10): : E350 - E350
  • [24] Innovations in cancer immunotherapy: chimeric antigen receptor T-cell therapy (CAR-T)
    Brown, Kevin
    Seftel, Matthew D.
    Hay, Kevin A.
    CANADIAN MEDICAL ASSOCIATION JOURNAL, 2021, 193 (33) : E1300 - E1302
  • [25] Patterns of Failure Following Chimeric Antigen Receptor T-cell (CAR-T) Therapy
    Figura, N. B.
    Jain, M. D.
    Sim, A. J.
    Chavez, J. C.
    Shah, B. D.
    Khimani, F.
    Lazaryan, A.
    Liu, H. D.
    Kim, S.
    Locke, F. L.
    Robinson, T. J.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2019, 105 (01): : S66 - S67
  • [26] Infections after chimeric antigen receptor (CAR)-T-cell therapy for hematologic malignancies
    Kampouri, Eleftheria
    Little, Jessica S.
    Rejeski, Kai
    Manuel, Oriol
    Hammond, Sarah P.
    Hill, Joshua A.
    TRANSPLANT INFECTIOUS DISEASE, 2023, 25
  • [27] Potential of Glioblastoma-Targeted Chimeric Antigen Receptor (CAR) T-Cell Therapy
    Salinas, Ryan D.
    Durgin, Joseph S.
    O'Rourke, Donald M.
    CNS DRUGS, 2020, 34 (02) : 127 - 145
  • [28] GEOGRAPHIC TRENDS IN CHIMERIC ANTIGEN RECEPTOR (CAR) T-CELL THERAPY ACCESS AND UTILIZATION
    McBride, K.
    Snyder, S.
    Serrano-Rubio, D.
    Gitlin, M.
    VALUE IN HEALTH, 2024, 27 (06) : S218 - S218
  • [29] Infections after chimeric antigen receptor (CAR)-T-cell therapy for hematologic malignancies
    Kampouri, Eleftheria
    Little, Jessica S.
    Rejeski, Kai
    Manuel, Oriol
    Hammond, Sarah P.
    Hill, Joshua A.
    TRANSPLANT INFECTIOUS DISEASE, 2023, 25
  • [30] MANAGEMENT OF COAGULOPATHY ASSOCIATED WITH TISAGENLECLEUCEL CHIMERIC ANTIGEN RECEPTOR (CAR) T-CELL THERAPY
    Buechner, Jochen
    Grupp, Stephan A.
    Maude, Shannon L.
    Hiramatsu, Hidefumi
    Teachey, David
    Wood, Patricia
    Awasthi, Rakesh
    Yi, Lan
    De Moerloose, Barbara
    PEDIATRIC BLOOD & CANCER, 2018, 65